Optimizing the therapeutic window of sirolimus by monitoring blood concentration for the treatment of immune thrombocytopenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimizing the therapeutic window of sirolimus by monitoring blood concentration for the treatment of immune thrombocytopenia

Published:2023-11-20 Issue:1 Volume:34 Page:
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Zhang Yun¹²,Quan Yao¹,Wang Dan¹³,Cassady Kaniel⁴,Zou Wenhang⁵,Xiong Jingkang¹,Yao Han¹,Deng Xiaojuan¹,Wang Ping¹,Yang Shijie¹,Zhang Xi¹,Feng Yimei¹

Affiliation:

1. Medical Center of Hematology, The Xinqiao Hospital of Army Medical University, Chongqing, China

2. Department of Clinical Laboratory, Children’s Hospital of Chongqing Medical University, Chongqing, China

3. Department of Hematology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China

4. Regeneron Pharmaceuticals, Tarrytown, NY, USA

5. Department of Infectious Disease, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

Funder

the National Natural Science Foundation of China

Chongqing Natural Science Foundation Innovative Group Program

General Project of Chongqing Natural Science

Chongqing Science and Health Joint Medical Research Program

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2023.2277831

Reference30 articles.

1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

2. The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety

3. Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study

4. Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial

5. Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution’s Experience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3